Multiple hydrogen bonding driven supramolecular architectures and their biomedical applications
Y Liu, L Wang, L Zhao, Y Zhang, ZT Li… - Chemical Society …, 2024 - pubs.rsc.org
Supramolecular chemistry combines the strength of molecular assembly via various
molecular interactions. Hydrogen bonding facilitated self-assembly with the advantages of …
molecular interactions. Hydrogen bonding facilitated self-assembly with the advantages of …
Insulin receptor isoforms in physiology and disease: an updated view
The insulin receptor (IR) gene undergoes differential splicing that generates two IR isoforms,
IR-A and IR-B. The physiological roles of IR isoforms are incompletely understood and …
IR-A and IR-B. The physiological roles of IR isoforms are incompletely understood and …
The emerging role of RNA as a therapeutic target for small molecules
CM Connelly, MH Moon, JS Schneekloth - Cell chemical biology, 2016 - cell.com
Recent advances in understanding different RNAs and unique features of their biology have
revealed a wealth of information. However, approaches to identify small molecules that …
revealed a wealth of information. However, approaches to identify small molecules that …
Small molecule approaches to targeting RNA
The development of innovative methodologies to identify RNA binders has attracted
enormous attention in chemical biology and drug discovery. Although antibiotics targeting …
enormous attention in chemical biology and drug discovery. Although antibiotics targeting …
MBNL proteins and their target RNAs, interaction and splicing regulation
Muscleblind-like (MBNL) proteins are key regulators of precursor and mature mRNA
metabolism in mammals. Based on published and novel data, we explore models of tissue …
metabolism in mammals. Based on published and novel data, we explore models of tissue …
Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1
Single-agent, single-target therapeutic approaches are often limited by a complex disease
pathobiology. We report rationally designed, multi-target agents for myotonic dystrophy type …
pathobiology. We report rationally designed, multi-target agents for myotonic dystrophy type …
A designed small molecule inhibitor of a non-coding RNA sensitizes HER2 negative cancers to herceptin
A small molecule (1) with overlap** affinity for two microRNA (miRNA) precursors was
used to inform design of a dimeric compound (2) selective for one of the miRNAs. In …
used to inform design of a dimeric compound (2) selective for one of the miRNAs. In …
Synthetic small-molecule RNA ligands: future prospects as therapeutic agents
A Di Giorgio, M Duca - MedChemComm, 2019 - pubs.rsc.org
RNA is one of the most intriguing and promising biological targets for the discovery of
innovative drugs in many pathologies and various biologically relevant RNAs that could …
innovative drugs in many pathologies and various biologically relevant RNAs that could …
Using genome sequence to enable the design of medicines and chemical probes
AJ Angelbello, JL Chen, JL Childs-Disney… - Chemical …, 2018 - ACS Publications
Rapid progress in genome sequencing technology has put us firmly into a postgenomic era.
A key challenge in biomedical research is harnessing genome sequence to fulfill the …
A key challenge in biomedical research is harnessing genome sequence to fulfill the …
Insights into the development of chemical probes for RNA
Over the past decade, the RNA revolution has revealed thousands of non-coding RNAs that
are essential for cellular regulation and are misregulated in disease. While the development …
are essential for cellular regulation and are misregulated in disease. While the development …